CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (1,082,050)	$ (1,130,308)
Adjustments to reconcile net loss to cash and cash equivalents used in operating activities:
Depreciation and amortization	9,662	20,620
Realized loss on investments in available-for-sale securities	0	79,983
Write down of other receivables	108,961	278,089
Gain on settlement of liabilities	0	(34,759)
Share-based compensation	150,999	38,004
Unrealized loss on stock price guarantee	345,542	375,147
Changes in assets and liabilities:
Accounts receivable	(73)	225,799
Other receivables	0	214,759
Prepaid expenses and other current assets	25,961	8,936
Advanced royalties	0	(2,042)
Deposits and other assets	11,055	(17,072)
Accounts payable	(86,751)	(347,555)
Accrued expenses	(3,771)	(11,193)
Deferred revenues	(889)	(13,614)
Net cash and cash equivalents used in operating activities	(521,354)	(315,206)
Cash flows from investing activities:
Proceeds from sale of investments in available-for-sale securities	0	157,650
Net cash and cash equivalents provided by investing activities	0	157,650
Cash flows from financing activities:
Payments on capital leases	(11,291)	(18,104)
Proceeds from issuance of common stock	195,000	0
Net cash and cash equivalents provided by (used in) financing activities	183,709	(18,104)
Net change in cash and cash equivalents	(337,645)	(175,660)
Cash and cash equivalents, beginning of period	651,318	463,285
Cash and cash equivalents, end of period	313,673	287,625
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Income taxes paid	974	3,971
Interest paid	634	920
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES
Issuance of previously subscribed common stock	$ 25,000	$ 0